Outcomes of CMML Patients Undergoing Allo-HCT Are Significantly Worse Compared to MDS—A Study of the CMWP of the EBMT

0
110
Patients ≥18 years with chronic myelomonocytic leukemia and myelodysplastic syndromes undergoing hematopoietic cell transplantation reported to the EBMT registry were analyzed.
[American Journal Of Hematology]
Full Article